Khodavirdipour Amir, Chamanrokh Parastoo, Alikhani Mohammad Yousef, Alikhani Mohammad Sina
Department of Molecular Genetics, University of Tabriz, Tabriz, Iran.
Dr. Rokh International Institute of Education and Health, Los Angeles, CA, United States.
Front Microbiol. 2022 Feb 11;13:718786. doi: 10.3389/fmicb.2022.718786. eCollection 2022.
The COVID-19 pandemic had anomalous yet inevitable impacts on the world's economies, healthcare systems, and all other aspects of life. Researchers began to uncover hidden routes to find a new horizon of hope using underrated resources. Biosurfactants are sustainable biomolecules with an active surface, unique characteristics, and extensive uses. species showed the highest amount of biosurfactant activities and is one of them. The antiviral, antimicrobial, and anti-inflammatory activity of was proven recently. The great advantage is its non-toxic nature. Pro-inflammatory cytokines including IL-1 β, 6, 8, 12, 18, and TNF-(α are secreted in higher amounts when neutrophils and monocytes are triggered by biosurfactant bacteria. This point of view furnishes the potential application of B. subtilis and its biomolecules against COVID-19, either in the form of a vaccine/therapeutic agent, for a greener environment, healthier life, and environmental sustainability. Further and clinical trials are needed to validate this hypothesis.
新冠疫情对世界经济、医疗系统及生活的所有其他方面产生了异常却不可避免的影响。研究人员开始探索利用被低估的资源来寻找新希望的途径。生物表面活性剂是具有活性表面、独特特性和广泛用途的可持续生物分子。某些物种表现出最高水平的生物表面活性剂活性,[物种名称]就是其中之一。[物种名称]的抗病毒、抗菌和抗炎活性最近得到了证实。其最大优势在于无毒性质。当中性粒细胞和单核细胞被生物表面活性剂细菌触发时,包括白细胞介素-1β、6、8、12、18和肿瘤坏死因子-α在内的促炎细胞因子会大量分泌。这一观点为枯草芽孢杆菌及其生物分子以疫苗/治疗剂的形式对抗新冠疫情提供了潜在应用前景,以实现更绿色的环境、更健康的生活和环境可持续性。还需要进一步的[研究内容]和临床试验来验证这一假设。
Front Microbiol. 2022-2-11
J Appl Microbiol. 2008-6
Curr Opin Environ Sci Health. 2020-10
J Appl Microbiol. 2015-10
Appl Environ Microbiol. 2024-11-20
Molecules. 2024-5-28
Pharmaceutics. 2023-8-18
Vaccines (Basel). 2022-6-24
Front Med (Lausanne). 2022-7-1
Int J Mol Sci. 2022-1-8
Electrochim Acta. 2022-1-20
Glob Med Genet. 2021-9-16
Micromachines (Basel). 2021-4-2
Drug Discov Today. 2021-8
Glob Med Genet. 2021-3
Pharmaceutics. 2020-11-16